154sek
-2,4 %
Date:2024-11-22Time:12:50:26Latest report:Q3-2024List:First NorthTicker:SPEC
Market Cap:153 msekEnterprise Value:131 msekNet Sales:- msekEarnings:-22,7 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:1,54
MA50:1,86
MA200:2,38
Price/MA200:-33,7 %
RSI (14):48,1
Price/MA50:-15,1 %

Description

SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.

Medical Equipment